Skip to main content
Article
Protection against radiotherapy-induced toxicity
Antioxidants
  • Susan Hall, Griffith University
  • Santosh Rudrawar, Griffith University
  • Matthew Zunk, Griffith University
  • Nijole Bernaitis, Griffith University
  • Devinder Arora, Griffith University
  • Catherine M. McDermott, Bond University
  • Shailendra Anoopkumar-Dukie, Griffith University
Date of this Version
7-5-2016
Document Type
Journal Article
Publication Details

Published version

Hall, S., Rudrawar, S., Zunk, M., Bernaitis, N., Arora, D., McDermott, C. M., & Anoopkumar-Dukie, S. (2016). Protection against radiotherapy-induced toxicity. Antioxidants, 5(3), 22.

Access the journal

Copyright © 2016 The Authors; licensee MDPI, Basel, Switzerland.

Distribution License
Creative Commons Attribution 4.0
Disciplines
Abstract
Radiation therapy is a highly utilized therapy in the treatment of malignancies with up to 60% of cancer patients receiving radiation therapy as a part of their treatment regimen. Radiation therapy does, however, cause a wide range of adverse effects that can be severe and cause permanent damage to the patient. In an attempt to minimize these effects, a small number of compounds have been identified and are in use clinically for the prevention and treatment of radiation associated toxicities. Furthermore, there are a number of emerging therapies being developed for use as agents that protect against radiation-induced toxicities. The aim of this review was to evaluate and summarise the evidence that exists for both the known radioprotectant agents and the agents that show promise as future radioprotectant agents.
Citation Information
Susan Hall, Santosh Rudrawar, Matthew Zunk, Nijole Bernaitis, et al.. "Protection against radiotherapy-induced toxicity" Antioxidants Vol. 5 Iss. 3 (2016) p. 22 ISSN: 2076-3921
Available at: http://works.bepress.com/catherine_mcdermott/20/